Summary
The objectives of the study were to assess the effects of moderate sodium restriction on blood pressure in insulin-dependent diabetic (IDDM) patients with nephropathy and high normal or mildly hypertensive blood pressure (primary objective), and to document possible associated changes of exchangeable body sodium, body volumes, components of the renin-angiotensin-aldosterone system, atrial natriuretic peptide, and catecholamines (secondary objective). Sixteen patients with untreated systolic blood pressure ≥ 140 <160 mmHg and/or diastolic blood pressure ≥ 85 <100 mmHg were included in a double-blind, randomized, placebo-controlled trial. After a 4-week run-in period on their usual diet and a 2-week dietary training period to reduce sodium intake to about 90 mmol/day, eight patients received 100 mmol/day sodium supplement (group 2) and eight patients a matching placebo (group 1) for 4 weeks while continuing on the reduced-sodium diet. Patients were examined at weekly intervals. Main response variables were mean values of supine and sitting systolic and diastolic blood pressure as measured in the clinic and by the patients at home. The differences in blood pressure between the beginning and the end of the blinded 4-week study period were calculated and the differences in changes between the two patient groups were regarded as the main outcome parameters. During the blinded 4-week study period, average urinary sodium excretion was 92±33 (mean ± SD) mmol/day in group 1 and 199±52 mmol/day in group 2 (p=0.0002). The differences in blood pressure changes between the two patient groups were 3.9(−1.2 to 9) mmHg [mean (95% confidence intervals)] for systolic home blood pressure, 0.9(−3.7 to 5.5) mmHg for diastolic home blood pressure, 4.9(−3.3 to 13.1) mmHg for clinic systolic blood pressure and 5.3(1 to 9.7 mmHg, p=0.02) for clinic diastolic blood pressure. Combining all patients, there were relevant associations between changes of urinary sodium excretion and blood volume (Spearman correlation coefficient r=0.57), blood pressure and angiotensin II (diastolic: r=−0.7; systolic: r=−0.48), and exchangeable body sodium and renin activity (r=−0.5). In conclusion, in this study of IDDM patients with nephropathy and high normal or mildly hypertensive blood pressure, a difference in sodium intake of about 100 mmol/day for a period of 4 weeks led to a slight reduction of clinic diastolic blood pressure. Studies including larger numbers of patients with various stages of nephropathy and hypertension are needed to definitely clarify the effects of sodium restriction in IDDM.
Article PDF
Similar content being viewed by others
Abbreviations
- ACE:
-
Angiotensin converting enzyme
- ANP:
-
atrial natriuretic peptide
- CV:
-
coefficient of variation
- GFR:
-
glomerular filtration rate
- RPF:
-
renal plasma flow
- PAH:
-
paraaminohippuric acid
References
de Châtel R, Weidmann P, Flammer J, Ziegler WH, Beretta-Piccoli C, Vetter W, Reubi FC (1977) Sodium, renin, aldosterone, catecholamines, and blood pressure in diabetes mellitus. Kidney Int 12: 412–421
Weidmann P, Beretta-Piccoli C, Trost BN (1985) Pressor factors and responsiveness in hypertension accompanying diabetes mellitus. Hypertension 7[Suppl 2]:33–42
Weidmann P, Ferrari P (1991) Central role of sodium in hypertension in diabetic subjects. Diabetes Care 14: 220–232
Trevisan R, Fioretto P, Semplicini A et al. (1990) Role of insulin and atrial natriuretic peptide in sodium retention in insulin-treated IDDM patients during isotonic volume expansion. Diabetes 39: 289–298
O'Hare JA, Ferriss JB, Brady D, Twomey B, O'Sullivan DJ (1985) Exchangeable sodium and renin in hypertensive diabetic patients with and without nephropathy. Hypertension 7[Suppl 2]:43–48
Feldt-Rasmussen B, Mathiesen ER, Deckert T, Giese J, Christensen NJ, Bent-Hansen L, Nielsen MD (1987) Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30: 610–617
Tuck M, Corry D, Trujillo A (1990) Salt-sensitive blood pressure and exaggerated vascular reactivity in the hypertension of diabetes mellitus. Am J Med 88: 210–216
Diabetes and Nutrition Study Group of the European Association for the Study of Diabetes-1988 (1988) Nutritional recommendations for individuals with diabetes mellitus. Diab Nutr Metab 1: 145–149
Alderman MH (1994) Non-pharmacological treatment of hypertension. Lancet 344: 307–311
Dodson PM, Beevers M, Hallworth R, Webberley MJ, Fletcher RF, Taylor KG (1989) Sodium restriction and blood pressure in hypertensive type II diabetics: randomised blind controlled and crossover studies of moderate sodium restriction and sodium supplementation. BMJ 298: 227–230
Mogensen CE (1982) Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. BMJ 285: 685–688
Parving HH, Andersen AR, Smidt UM, Svensen PA (1983) Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet I:1175–1179
Mathiesen ER, Borch-Johnsen K, Jensen DV, Deckert T (1989) Improved survival in patients with diabetic nephropathy. Diabetologia 32: 884–886
The Working Group on Hypertension in Diabetes (1987) Statement on hypertension in diabetes mellitus. Final report. Arch Int Med 147: 830–842
Krans HMJ, Porta M, Keen H (1992) Diabetes care and research in Europe, the St Vincent declaration action programme. Implementation document. Giorn Ital Diabetol 12[Suppl 2]:22–26
American Diabetes Association (1993) Treatment of hypertension in diabetes. Diabetes Care 16: 1394–1401
Mühlhauser I, Sawicki P, Didjurgeit U, Jörgens V, Berger M (1988) Uncontrolled hypertension in type 1 diabetes: assessment of patients' desires about treatment and improvement of blood pressure control by a structured treatment and teaching programme. Diabet Med 5: 693–698
Sawicki PT, Didjurgeit U, Mühlhauser I, Bender R, Heinemann L, Berger M (1994) Smoking is associated with progression of diabetic nephropathy. Diabetes Care 17: 126–131
Bock J, Toutenburg H (1991) Sample size determination in clinical research. In: Rao CR, Chakraborty R (eds) Handbook of statistics, vol 8. Elsevier, Amsterdam, pp 515–538
Jörgens V, Grüsser M, Bott U, Mühlhauser I, Berger M (1993) Effective and safe translation of intensified insulin therapy to general internal medicine departments. Diabetologia 36: 99–105
Venhaus A, Chantelau E (1988) Self-selected unrefined and refined carbohydrate diets do not affect metabolic control in pump-treated diabetic patients. Diabetologia 31: 153–157
Heering P, Kutkuhn B, Kreuzpaintner G, Reinhard T, Sundmacher R, Grabensee B (1991) Untersuchungen zur Nierenfunktion nierengesunder Patienten unter Ciclosporin. Klin Wochenschr 69: 880–886
Plum J, Grabensee B (1991) Atrial natriuretic peptide in dialysis patients under various conditions of volume homeostasis. J Int Med 229: 209–216
Oster P, Hackenthal E, Hepp R (1973) Radioimmunoassay of angiotensin II in rat plasma. Experientia 29: 353–354
Schnurr E, Lahme W, Küppers H (1980) Measurements of renal clearance of inulin and PAH in the steady state without urine collection. Clin Nephrol 13: 26–29
Kunkel R, Oberhausen E (1968) Die gleichzeitige Bestimmung des Gesamtkaliums und des austauschbaren Natriums beim Menschen. In: Hoffmann G, Höfer R (eds) Radionuklide in Kreislaufforschung und Kreislaufdiagnose. Schattauer, Stuttgart, New York, pp 411–415
Miller H, Wilson GM (1953) The measurement of exchangeable sodium in man using the isotope Na-24. Clin Science 12: 97–111
Hermann H-J (1982) Nuklearmedizin. Urban und Schwarzenberg München, Wien, Baltimore, pp 337–347
Westfall PH, Young SS (1993) Resampling-based multiple testing. Wiley, New York
SAS/STAT (1987) Guide for Personal Computers. Version 6 edn. SAS Institute Inc, Cary, N.C.
SAS Technical Report P-229 (1992) SAS/STAT Software: Changes and Enhancements, Release 6.07. SAS Institute Inc., Cary, N.C.
Hansen KW, Christiansen CK, Andersen PH, Pedersen MM, Christiansen JS, Mogensen CE (1992) Ambulatory blood pressure in microalbuminuric type 1 diabetic patients. Kidney Int 41: 847–854
Hansen KW, Pedersen MM, Marshall SM, Christiansen JS, Mogensen CE (1992) Circadian variation of blood pressure in patients with diabetic nephropathy. Diabetologia 35: 1074–1079
Liniger C, Favre L, Assal J-Ph (1991) Twenty-four hour blood pressure and heart rate profiles of diabetic patients with abnormal cardiovascular reflexes. Diabet Med 8: 420–427
Brochner-Mortensen J (1973) Glomerular filtration rate and extracellular fluid volume during normoglycemia and moderate hyperglycemia in diabetes. Scand J Clin Lab Invest 32: 311–316
MacGregor GA, Markandu ND, Sagnella GA, Singer DRJ, Cappuccio FP (1989) Double-blind study of three sodium intakes and long-term effects of sodium restriction in essential hypertension. Lancet II:1244–1247
Alderman MH, Madhavan S, Ooi WL, Cohen H, Sealey JE, Laragh JH (1991) Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med 324: 1098–1104
Meade TW, Cooper JA, Peart WS (1993) Plasma renin activity and ischaemic heart disease. N Engl J Med 329: 616–669
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mühlhauser, I., Prange, K., Sawicki, P.T. et al. Effects of dietary sodium on blood pressure in IDDM patients with nephropathy. Diabetologia 39, 212–219 (1996). https://doi.org/10.1007/BF00403965
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00403965